Liberty Health Sciences (CSE: LHS) (OTCBB: LHSIF) announced an agreement to license and sell Resolve Digital Health’s metered cannabis delivery systems to medical patients in Florida. The agreement is subject to approval by the Florida state Department of Health.
Resolve’s technology uses artificial intelligence to track patient usage data through a mobile app, allowing doctors and patients to monitor and improve treatment over time. Resolve’s Breeze Smart Inhalers allow patients to vary dosage based on amount of pain and machine learning analysis of activity patterns such as time of day, sleep history and other data.
Liberty stock moved up 7% in the last 5 days to $1.14. It’s 52 week range is $0.750 – $1.750 and market cap is $320.94m.
Source: Liberty Press Release